| Legal ForumsRegisterSign inBankruptcyBusinessCriminalEmploymentFamilyImmigrationReal EstateMore... | ChatUpcomingArchiveHelpAsk a LawyerMost Recent Q&AAsk a QuestionAsk a Lawyer Archive |
| State Law and AgenciesU.S. ConstitutionFederal Courts & LawsU.S. Small Claims CourtTraffic Violations in Your StateFederal Government AgenciesLegal DictionaryFree Case Law Research |

The FDA urges caution when searching for H1N1 products on the
internet because many unapproved H1N1 products purport to prevent,
diagnose, or treat H1N1.
The FDA warns consumers of the potential danger of these products
and cautions consumers that they should use only FDA approved products
from licensed pharmacies. The potential dangers of using unapproved FDA
products include an "increased risk of suffering life-threatening
adverse events such as side effects from inappropriately using
prescription medications, dangerous drug interactions, contaminated
drugs, and impure or unknown ingredients found in unapproved drugs."
Currently, Tamiflu and Relenza are the only two FDA-approved antiviral drugs to treat H1N1.
With unapproved products, you can't be sure what you're getting. For
example, the FDA, in monitoring the web for unapproved products,
ordered a shipment of what was purported online to be Tamiflu. The FDA
received an an unmarked envelope postmarked from India. The envelope
contained "unlabeled, white tablets taped between two pieces of paper."
The tablets were analyzed, and it was determined that they contained
talc and acetaminophen (fever reducer and pain reliever). The tablets
did not contain oseltamivir, the active ingredient of Tamiflu.
Among the products that the FDA has targeted:
